{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:16:05Z","timestamp":1762103765541,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009460","name":"Society for Cultural Anthropology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000844","name":"European Space Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003958","name":"Stichting voor de Technische Wetenschappen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bja.2021.01.032","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T15:09:09Z","timestamp":1615043349000},"page":"958-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model"],"prefix":"10.1016","volume":"126","author":[{"given":"Derek J.B.","family":"Kleinveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza","family":"Botros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Adrie W.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Kers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurjan","family":"Aman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus W.","family":"Hollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole P.","family":"Juffermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2021.01.032_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bja.2021.01.032_bib2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/acem.13223","article-title":"The epidemiology of emergency department trauma discharges in the United States","volume":"24","author":"DiMaggio","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.bja.2021.01.032_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/jth.14378","article-title":"Towards patient-specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry","volume":"17","author":"Juffermans","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2021.01.032_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/bjs.10330","article-title":"Combined effect of therapeutic strategies for bleeding injury on early survival, transfusion needs and correction of coagulopathy","volume":"104","author":"Balvers","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.bja.2021.01.032_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1802345","article-title":"Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock","volume":"379","author":"Sperry","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bja.2021.01.032_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SHK.0000000000000999","article-title":"Endotheliopathy of trauma is an on-scene phenomenon, and is associated with multiple organ dysfunction syndrome: a prospective observational study","volume":"49","author":"Naumann","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.bja.2021.01.032_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jamcollsurg.2018.09.003","article-title":"Elevated syndecan-1 after trauma and risk of sepsis: a secondary analysis of patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial","volume":"227","author":"Wei","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.bja.2021.01.032_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189870","article-title":"Endotheliopathy is associated with higher levels of cell-free DNA following major trauma: a prospective observational study","volume":"12","author":"Naumann","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bja.2021.01.032_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/SLA.0000000000001664","article-title":"Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation","volume":"265","author":"Sordi","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.bja.2021.01.032_bib10","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2011-11-390120","article-title":"Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and\/or nilotinib therapy failure","volume":"119","author":"Khoury","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bja.2021.01.032_bib11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3324\/haematol.2017.171249","article-title":"Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I\/II study","volume":"103","author":"Gambacorti-Passerini","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bja.2021.01.032_bib12","doi-asserted-by":"crossref","first-page":"e716","DOI":"10.1016\/S1470-2045(17)30840-9","article-title":"Bosutinib more effective than imatinib in CML","volume":"18","author":"Gourd","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bja.2021.01.032_bib13","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1161\/CIRCULATIONAHA.112.134304","article-title":"Effective treatment of edema and endothelial barrier dysfunction with imatinib","volume":"126","author":"Aman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bja.2021.01.032_bib14","doi-asserted-by":"crossref","first-page":"jcs240077","DOI":"10.1242\/jcs.240077","article-title":"Bosutinib prevents vascular leakage by reducing focal adhesion turnover and reinforcing junctional integrity","volume":"133","author":"Botros","year":"2020","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.bja.2021.01.032_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10428194.2018.1466294","article-title":"Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells","volume":"60","author":"Gover-Proaktor","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bja.2021.01.032_bib16","doi-asserted-by":"crossref","first-page":"L1294","DOI":"10.1152\/ajplung.00031.2015","article-title":"Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury","volume":"309","author":"Rizzo","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bja.2021.01.032_bib17","doi-asserted-by":"crossref","first-page":"L259","DOI":"10.1152\/ajplung.00323.2014","article-title":"Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury","volume":"308","author":"Letsiou","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bja.2021.01.032_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bja.2017.11.095","article-title":"Reduction of vascular leakage by imatinib is associated with preserved microcirculatory perfusion and reduced renal injury markers in a rat model of cardiopulmonary bypass","volume":"120","author":"Koning","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2021.01.032_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00000658-200003000-00013","article-title":"Inhibition of tyrosine kinase signaling after trauma-hemorrhage: a novel approach for improving organ function and decreasing susceptibility to subsequent sepsis","volume":"231","author":"Jarrar","year":"2000","journal-title":"Ann Surg"},{"key":"10.1016\/j.bja.2021.01.032_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40635-019-0242-5","article-title":"Use of a high platelet-to-RBC ratio of 2:1 is more effective in correcting trauma-induced coagulopathy than a ratio of 1:1 in a rat multiple trauma transfusion model","volume":"7","author":"Kleinveld","year":"2019","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.bja.2021.01.032_bib21","first-page":"72","article-title":"Blood volume in the rat","volume":"26","author":"Lee","year":"1985","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.bja.2021.01.032_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchromb.2015.09.030","article-title":"A\u00a0simple method for the determination of Bosutinib in rat plasma by UPLC-MS\/MS","volume":"1004","author":"Xu","year":"2015","journal-title":"J\u00a0Chromatogr B"},{"key":"10.1016\/j.bja.2021.01.032_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.12659\/MSMBR.889518","article-title":"Micro-osmotic pumps for continuous release of the tyrosine kinase inhibitor bosutinib in juvenile rats and its impact\u00a0on bone growth","volume":"19","author":"Tauer","year":"2013","journal-title":"Med Sci Monit Basic Res"},{"key":"10.1016\/j.bja.2021.01.032_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/trf.15039","article-title":"Washing or filtering of blood products does not improve outcome in a rat model of trauma and multiple transfusion","volume":"59","author":"Wirtz","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.bja.2021.01.032_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.intimp.2018.12.062","article-title":"Inhibition of spleen tyrosine kinase signaling protects against acute lung injury through blockade of NADPH oxidase and IL-17A in neutrophils and gammadelta T cells respectively in mice","volume":"68","author":"Nadeem","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bja.2021.01.032_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/ATVBAHA.115.305085","article-title":"Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome","volume":"35","author":"Rizzo","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bja.2021.01.032_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccc.2016.08.006","article-title":"Postinjury inflammation and organ dysfunction","volume":"33","author":"Sauaia","year":"2017","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.bja.2021.01.032_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/SHK.0000000000000779","article-title":"Contemporary patterns of multiple organ dysfunction in trauma","volume":"47","author":"Shepherd","year":"2017","journal-title":"Shock"},{"key":"10.1016\/j.bja.2021.01.032_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/BJ20141165","article-title":"The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases","volume":"465","author":"Ozanne","year":"2015","journal-title":"Biochem J"},{"key":"10.1016\/j.bja.2021.01.032_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jamcollsurg.2017.05.012","article-title":"Syndecan-1: a quantitative marker for the endotheliopathy of trauma","volume":"225","author":"Gonzalez Rodriguez","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.bja.2021.01.032_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/SLA.0000000000001751","article-title":"Traumatic endotheliopathy: a prospective observational study of\u00a0424\u00a0severely injured patients","volume":"265","author":"Johansson","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.bja.2021.01.032_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cpdd.396","article-title":"Absolute bioavailability of bosutinib in healthy subjects from an open-label, randomized, 2-period crossover study","volume":"7","author":"Hsyu","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.bja.2021.01.032_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/2040620718756603","article-title":"Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study","volume":"9","author":"Kuo","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.bja.2021.01.032_bib34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/mco.2015.572","article-title":"Vascular endothelial growth factor receptor tyrosine kinase inhibitors versus bevacizumab in metastatic colorectal cancer: a systematic review and meta-analysis","volume":"3","author":"Lin","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.bja.2021.01.032_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SHK.0b013e31829040e3","article-title":"Acute coagulopathy of trauma in the rat","volume":"39","author":"Darlington","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.bja.2021.01.032_bib36","article-title":"Severe trauma and hemorrhage leads to platelet dysfunction and changes in cyclic nucleotides in the rat","author":"Darlington","year":"2019","journal-title":"Shock"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091221000908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091221000908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:14:48Z","timestamp":1762103688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091221000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0007091221000908"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2021.01.032","relation":{},"ISSN":["0007-0912"],"issn-type":[{"type":"print","value":"0007-0912"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2021.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}